Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1995 Jan;63(1):122–125. doi: 10.1128/iai.63.1.122-125.1995

Pure paraflagellar rod protein protects mice against Trypanosoma cruzi infection.

R A Wrightsman 1, M J Miller 1, J L Saborio 1, J E Manning 1
PMCID: PMC172967  PMID: 7806347

Abstract

The paraflagellar rod proteins (PAR) purified from Trypanosoma cruzi epimastigotes were shown to protect mice against an otherwise lethal challenge inoculum of 10(3) bloodstream-form trypomastigotes. The injection route used for immunization was shown to have a marked impact on the development of protective immunity. Mice receiving subcutaneous (s.c.) injections of PAR proteins had reduced bloodstream parasitemias and showed 100% survival following challenge. In contrast, mice immunized via the intraperitoneal (i.p.) route developed parasitemia levels equivalent to those of unimmunized controls and did not survive infection. Western blotting (immunoblotting) demonstrated that sera from both i.p. and s.c. immunized mice reacted specifically with PAR proteins; however, the antibody titer of the i.p. immunized mice was approximately 64-fold greater than that of the s.c. immunized mice, suggesting that the protective response in the s.c. immunized mice is cell mediated rather than humoral.

Full Text

The Full Text of this article is available as a PDF (247.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Araujo F. G. Development of resistance to Trypanosoma cruzi in mice depends on a viable population of L3T4+ (CD4+) T lymphocytes. Infect Immun. 1989 Jul;57(7):2246–2248. doi: 10.1128/iai.57.7.2246-2248.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Araujo F. G., Morein B. Immunization with Trypanosoma cruzi epimastigote antigens incorporated into iscoms protects against lethal challenge in mice. Infect Immun. 1991 Sep;59(9):2909–2914. doi: 10.1128/iai.59.9.2909-2914.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Beard C. A., Saborio J. L., Tewari D., Krieglstein K. G., Henschen A. H., Manning J. E. Evidence for two distinct major protein components, PAR 1 and PAR 2, in the paraflagellar rod of Trypanosoma cruzi. Complete nucleotide sequence of PAR. J Biol Chem. 1992 Oct 25;267(30):21656–21662. [PubMed] [Google Scholar]
  4. Brener Z. Biology of Trypanosoma cruzi. Annu Rev Microbiol. 1973;27:347–382. doi: 10.1146/annurev.mi.27.100173.002023. [DOI] [PubMed] [Google Scholar]
  5. González J., Araguth M. F., Yoshida N. Resistance to acute Trypanosoma cruzi infection resulting from immunization of mice with a 90-kilodalton antigen from metacyclic trypomastigotes. Infect Immun. 1991 Mar;59(3):863–867. doi: 10.1128/iai.59.3.863-867.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Kierszenbaum F., Pienkowski M. M. Thymus-dependent control of host defense mechanisms against Trypanosoma cruzi infection. Infect Immun. 1979 Apr;24(1):117–120. doi: 10.1128/iai.24.1.117-120.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Lanar D. E. Growth and differentiation of Trypanosoma cruzi cultivated with a Triatoma infestans embryo cell line. J Protozool. 1979 Aug;26(3):457–462. doi: 10.1111/j.1550-7408.1979.tb04653.x. [DOI] [PubMed] [Google Scholar]
  8. McCabe R. E., Remington J. S., Araujo F. G. In vivo and in vitro effects of cyclosporin A on Trypanosoma cruzi. Am J Trop Med Hyg. 1985 Sep;34(5):861–865. doi: 10.4269/ajtmh.1985.34.861. [DOI] [PubMed] [Google Scholar]
  9. Pearce E. J., James S. L., Hieny S., Lanar D. E., Sher A. Induction of protective immunity against Schistosoma mansoni by vaccination with schistosome paramyosin (Sm97), a nonsurface parasite antigen. Proc Natl Acad Sci U S A. 1988 Aug;85(15):5678–5682. doi: 10.1073/pnas.85.15.5678. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Rottenberg M. E., Bakhiet M., Olsson T., Kristensson K., Mak T., Wigzell H., Orn A. Differential susceptibilities of mice genomically deleted of CD4 and CD8 to infections with Trypanosoma cruzi or Trypanosoma brucei. Infect Immun. 1993 Dec;61(12):5129–5133. doi: 10.1128/iai.61.12.5129-5133.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Rottenberg M., Cardoni R. L., Andersson R., Segura E. L., Orn A. Role of T helper/inducer cells as well as natural killer cells in resistance to Trypanosoma cruzi infection. Scand J Immunol. 1988 Nov;28(5):573–582. doi: 10.1111/j.1365-3083.1988.tb01489.x. [DOI] [PubMed] [Google Scholar]
  12. Ruiz A. M., Esteva M., Cabeza Meckert P., Laguens R. P., Segura E. L. Protective immunity and pathology induced by inoculation of mice with different subcellular fractions of Trypanosoma cruzi. Acta Trop. 1985 Dec;42(4):299–309. [PubMed] [Google Scholar]
  13. Ruiz A. M., Esteva M., Riarte A., Subías E., Segura E. L. Immunoprotection of mice against Trypanosoma cruzi with a lyophilized flagellar fraction of the parasite plus adjuvant. Immunol Lett. 1986 Jan;12(1):1–4. doi: 10.1016/0165-2478(86)90072-6. [DOI] [PubMed] [Google Scholar]
  14. Ruiz A. M., Esteva M., Subias E., Moreno M., Rosenstein de Campanini A., Velazquez E., Segura E. L. Monoclonal antibodies against the flagellar fraction of epimastigotes of Trypanosoma cruzi: immunoprotection against metacyclic trypomastigotes obtained by immunization of mice with an affinity-purified antigen. Mol Biochem Parasitol. 1990 Feb;39(1):117–125. doi: 10.1016/0166-6851(90)90014-d. [DOI] [PubMed] [Google Scholar]
  15. Russo M., Starobinas N., Minoprio P., Coutinho A., Hontebeyrie-Joskowicz M. Parasitic load increases and myocardial inflammation decreases in Trypanosoma cruzi-infected mice after inactivation of helper T cells. Ann Inst Pasteur Immunol. 1988 May-Jun;139(3):225–236. doi: 10.1016/0769-2625(88)90136-5. [DOI] [PubMed] [Google Scholar]
  16. Saborio J. L., Manuel Hernandez J., Narayanswami S., Wrightsman R., Palmer E., Manning J. Isolation and characterization of paraflagellar proteins from Trypanosoma cruzi. J Biol Chem. 1989 Mar 5;264(7):4071–4075. [PubMed] [Google Scholar]
  17. Schmunis G. A., Cappa S. M., Traversa O. C., Janovsky J. F. The effect of immuno-depression due to neonatal thymectomy on infections with Trypanosoma cruzi in mice. Trans R Soc Trop Med Hyg. 1971;65(1):89–94. doi: 10.1016/0035-9203(71)90190-8. [DOI] [PubMed] [Google Scholar]
  18. Segura E. L., Paulone I., Cerisola J., Cappa S. M. Experimental Chagas' disease: protective activity in relation with subcellular fractions of the parasite. J Parasitol. 1976 Feb;62(1):131–133. [PubMed] [Google Scholar]
  19. Segura E. L., Vazquez C., Bronzina A., Campos J. M., Cerisola J. A., Cappa S. M. Antigens of the subcellular fractions of Trypanosoma cruzi. II. Flagellar and membrane fraction. J Protozool. 1977 Nov;24(4):540–543. doi: 10.1111/j.1550-7408.1977.tb01009.x. [DOI] [PubMed] [Google Scholar]
  20. Taibi A., Plumas-Marty B., Guevara-Espinoza A., Schöneck R., Pessoa H., Loyens M., Piras R., Aguirre T., Gras-Masse H., Bossus M. Trypanosoma cruzi: immunity-induced in mice and rats by trypomastigote excretory-secretory antigens and identification of a peptide sequence containing a T cell epitope with protective activity. J Immunol. 1993 Sep 1;151(5):2676–2689. [PubMed] [Google Scholar]
  21. Tarleton R. L. Depletion of CD8+ T cells increases susceptibility and reverses vaccine-induced immunity in mice infected with Trypanosoma cruzi. J Immunol. 1990 Jan 15;144(2):717–724. [PubMed] [Google Scholar]
  22. Wrightsman R., Krassner S., Watson J. Genetic control of responses to Trypanosoma cruzi in mice: multiple genes influencing parasitemia and survival. Infect Immun. 1982 May;36(2):637–644. doi: 10.1128/iai.36.2.637-644.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. de Souza W., Souto-Padrón T. The paraxial structure of the flagellum of trypanosomatidae. J Parasitol. 1980 Apr;66(2):229–236. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES